CLINICAL_TRIALS
trial_result
· 2016-07-15
Clinical Trial Update: Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 study of panobinostat as monotherapy in HER2-negative locally recurrent or metastatic breast cancer completed; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Translational Research in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-07-15